Acrivon Therapeutics, Inc.
ACRV
$1.52
-$0.06-3.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.93% | -31.05% | -23.88% | 36.06% | 40.82% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.31% | -27.69% | -45.69% | -21.96% | -3.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.69% | -31.02% | -24.10% | 34.94% | 40.05% |
|
|
|||||
| Total Current Assets | -33.69% | -31.02% | -24.10% | 34.94% | 40.05% |
| Net Property, Plant & Equipment | -7.59% | -5.74% | 9.15% | 4.85% | 1.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.60% | 0.33% | 107.87% | 141.18% | 177.44% |
| Total Assets | -34.02% | -32.32% | -31.23% | 46.32% | 42.18% |
|
|
|||||
| Total Accounts Payable | 200.40% | -33.86% | -7.77% | 79.52% | -84.98% |
| Total Accrued Expenses | -20.68% | 4.03% | 20.46% | 42.50% | 108.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.88% | 13.85% | 17.38% | 17.06% | 20.52% |
| Total Finance Division Other Current Liabilities | -- | -- | 99.65% | 143.75% | -- |
| Total Other Current Liabilities | -- | -- | 99.65% | 143.75% | -- |
| Total Current Liabilities | -9.00% | 0.49% | 19.03% | 49.87% | 29.40% |
|
|
|||||
| Total Current Liabilities | -9.00% | 0.49% | 19.03% | 49.87% | 29.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -40.61% | -39.29% | -34.78% | -31.19% | -31.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -13.14% | -6.16% | 7.01% | 27.24% | 16.00% |
|
|
|||||
| Common Stock & APIC | 3.74% | 3.82% | 3.48% | 56.36% | 57.05% |
| Retained Earnings | -39.55% | -46.94% | -56.66% | -63.01% | -69.19% |
| Treasury Stock & Other | -75.17% | -85.68% | 657.89% | 504.29% | 638.55% |
| Total Common Equity | -36.35% | -34.68% | -33.80% | 48.54% | 45.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.35% | -34.68% | -33.80% | 48.54% | 45.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.35% | -34.68% | -33.80% | 48.54% | 45.87% |
|
|
|||||